Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Peerj|March 27, 2020
Biochemical and biophysical characterisation of immunoglobulin free light chains derived from an initially unbiased population of patients with light chain diseaseRebecca Sternke-Hoffmann, Amelie Boquoi, David Lopez Y Niedenhoff, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2006
Coexpression of fragile histidine triad and c-kit is relevant for prediction of survival in patients with small cell lung cancerNina Rehfeld, Helene Geddert, Abedelsalam Atamna, et al.
Cancers|May 14, 2022
Opportunities for Participation in Randomized Controlled Trials for Patients with Multiple Myeloma: Trial Access Depends on Restrictive Eligibility Criteria and Patient ExpectationsAmelie Boquoi, Veronika Rings, Annemarie Mohring, et al.
Drug Delivery and Translational Research|January 2, 2023
A phase I first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone in patients with progressive multiple myelomaJosbert Metselaar, Twan Lammers, Amelie Boquoi, et al.
Leukemia & Lymphoma|December 11, 2007
Escalation therapy with bortezomib, dexamethasone and bendamustine for patients with relapsed or refractory multiple myelomaRoland Fenk, Mark Michael, Fabian Zohren, et al.
Leukemia & Lymphoma|June 11, 2011
Predictive factors for successful salvage high-dose therapy in patients with multiple myeloma relapsing after autologous blood stem cell transplantationRoland Fenk, Vanessa Liese, Florian Neubauer, et al.
European Journal of Haematology|December 23, 2018
Interaction of increasing ICU survival and admittance policies in patients with hematologic neoplasms: A single center experience with 304 patientsMustafa Kondakci, Marc C Reinbach, Ulrich Germing, et al.
European Journal of Medical Research|February 18, 2010
Bendamustine in patients with relapsed or refractory multiple myelomaM Michael, I Bruns, E Bölke, et al.
European Journal of Haematology|March 22, 2005
LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapySimona Martin, Christian Fischer, Maren Free, et al.
Annals of Hematology|March 30, 2019
Relapse patterns and treatment strategies in patients receiving allogeneic hematopoietic stem cell transplantation for myeloid malignanciesEsther Schuler, Sarah Boughoufala, Christina Rautenberg, et al.
Pageof 9